Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges

John Schrom; Carina Marquez; Chung-Yu Wang; Aditi Saxena; Anthea Mitchell; Salustiano Ribeiro; Genay Pilarowski; Robert Nakamura; Susana Rojas; Douglas Black; Maria Contreras Oseguera; Edgar Castellanos Diaz; Joselin Payan; Susy Rojas; Diane Jones; Valerie Tulier-Laiwa; Aleks Zavaleta; Jacqueline Martinez; Gabriel Chamie; Carol Glaser; Kathy Jacobson; Maya Petersen; Joseph DeRisi; Diane Havlir.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-22278913

Documentos relacionados

  1. Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges.
  2. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge : A Cross-Sectional Study.
  3. Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020.
  4. Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.
  5. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.
  6. SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
  7. Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant.
  8. Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
  9. One Swab Fits All: Performance of a Rapid, Antigen-Based SARS-CoV-2 Test Using a Nasal Swab, Nasopharyngeal Swab for Nasal Collection, and RT-PCR Confirmation from Residual Extraction Buffer.
  10. Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.